Neuroendocrine Tumors Of Midgut Origin clinical trials

Explore recruiting neuroendocrine tumors of midgut origin clinical trials.

Also recruiting in Europe

Neuroendocrine Tumors Of Midgut Origin trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized Interval Assessment trial of Lu177-Dotatate every 8 versus every 16 weeks in slowly progressive G1-2 advanced midgut neuroendocrine tumors (NETs) to Lower TOxicity.

Spain, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Neuroendocrine Tumors Of Midgut Origin trials by city

Neuroendocrine Tumors Of Midgut Origin in Toronto Neuroendocrine Tumors Of Midgut Origin in Vancouver Neuroendocrine Tumors Of Midgut Origin in Montreal Neuroendocrine Tumors Of Midgut Origin in Calgary Neuroendocrine Tumors Of Midgut Origin in Edmonton Neuroendocrine Tumors Of Midgut Origin in Ottawa Neuroendocrine Tumors Of Midgut Origin in Winnipeg Neuroendocrine Tumors Of Midgut Origin in Quebec City Neuroendocrine Tumors Of Midgut Origin in Hamilton Neuroendocrine Tumors Of Midgut Origin in Kitchener Neuroendocrine Tumors Of Midgut Origin in London Neuroendocrine Tumors Of Midgut Origin in Halifax Neuroendocrine Tumors Of Midgut Origin in New York Neuroendocrine Tumors Of Midgut Origin in Los Angeles Neuroendocrine Tumors Of Midgut Origin in Chicago Neuroendocrine Tumors Of Midgut Origin in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease